First New York Securities’s Allergan plc AGN Stock Holding History

First New York Securities’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-23	Closed	-$5.32K	–	318
2016 Q2	$5.32K	Sell	23 -10,800	-100%	-$2.49M	﹤0.01%	167
2016 Q1	$2.9M	Buy	+10,823	New	+$3.1M	2%	10
2015 Q2	–	Sell	-1,000	Closed	-$298K	–	578
2015 Q1	$298K	Buy	+1,000	New	+$285K	0.29%	45

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

First New York Securities's AGN Position: Q3 2016 in Review

First New York Securities sold out of Allergan plc (AGN) in Q3 2016, closing a stake of 23 shares — an estimated $5.32K sold.

First New York Securities first reported a position in AGN in Q1 2015 and held it in 3 quarters. The position peaked at $2.9M in Q1 2016. 1,105 funds tracked by Wall St. Rank hold AGN as of Q3 2016.

First New York Securities reported no remaining Allergan plc position as of Q3 2016 after selling out during the quarter.
First New York Securities sold 23 Allergan plc shares in Q3 2016, an estimated $5.32K.
First New York Securities first reported a position in Allergan plc in Q1 2015 and held it in 3 quarters.
First New York Securities's Allergan plc position peaked at $2.9M in Q1 2016.
1,105 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on First New York Securities's 13F filing for Q3 2016, filed 18 Oct 2016.